FDA Investigator L Gnnmassimia Massimilla, PharmD

L Gnnmassimia Massimilla, PharmD has inspections in 4 countries as of 05 May 2023. L Gnnmassimia Massimilla, PharmD has collaborated with a combinined 1194 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
67
Last Inspection Date:
05 May 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100003517
Country:
United States of America, Germany, Canada
Co-Investigator(s):
Alanna Lmussawwir Bias, Alia Legaux, Althea A Williams, Amy Kim, Amy W Yan Mai, Andrea P Scott, Andrew B Paglia, DPM, Anissa M Vargas, Armando A Gonzalez, Arthur S Williams, Jr, Benton M Ketron, Charisse K Green, Dave M Deroche, Demitria J Xiradakis, Dorothy W Lee, Eric W Anderson, Evelyn Taha, Fatima Bassa, Felix Maldonado, Geoffrey K Kilili, Gregson A Joseph, Helen B Ricalde, Iram R Hassan, PhD, Irina Gaberman, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Liubicich, Jorge C Rios, MD, Joy P Matthias, Karen L Kosar, Kenneth H Williams, Kent C Hermann, Kevin A Gonzalez, Kim M Downing, Kimberley A Ricketts, L Gnnmassimua Massimulla, L'oreal F Walker, Lawton W Lum, Leena Thomas, Lisa Mathew, Mark E Chan, Matthew A Spataro, Michael G Mayfield, Mindy M Chou, Myra K Casey, Neali H Lucas, Nealie C Newberger, Omadevi Somai, Investigator, Paul E Stein, Paul Mouris, Perry T Nichols, Peter Abel, Philip F Istafanos, DMV, MS, Samuel Eskenazi, Samuel T Walker, Satheesh Thomas, Sergio Chavez (NMI), Simone E Pitts, Sony Mathews, Sripal R Mada, PhD, Thomas P Hansen, Uduak M Inokon, Valentino Fiorella, Valerie J Grecek Trinh, Winston R Alejo, Yvette Mlacour Davis, Yvonne M Santiago

L Gnnmassimia Massimilla, PharmD's Documents

Publish Date Document Type Title
March, 2001 FDA 483 Lenox Hill Hospital - Form 483, 2001-03-09
November, 2002 EIR Barr Laboratories Inc. - EIR, 2002-11-12
May, 2001 FDA 483 James C.-Y Chou, M.D. - Form 483, 2001-05-02
October, 2002 FDA 483 Sanofi-Synthelabo Inc. - Form 483, 2002-10-15
April, 2000 FDA 483 Medtronic Vascular, Inc. - Form 483, 2000-04-28
April, 2000 EIR Medtronic Vascular, Inc. - EIR, 2000-04-28
May, 2003 EIR Blair Ford, MD - EIR, 2003-05-05
January, 2000 FDA 483 Arizona Heart Institute - Form 483, 2000-01-11
May, 2001 EIR Samin K. Sharma - EIR, 2001-05-18
November, 2002 FDA 483 Response Barr Laboratories Inc. - Form 483R, 2003-02-26
May, 2001 FDA 483 Response James C.-Y Chou, M.D. - Form 483R, 2001-06-05
July, 2001 FDA 483 Response American Health Foundation - Form 483R, 2001-08-15
May, 2003 FDA 483 Blair Ford, MD - Form 483, 2003-05-05
March, 2005 FDA 483 Orthometrix, Inc. - Form 483, 2005-03-04
November, 2001 EIR Mark P.Figgie, M.D. - EIR, 2001-11-20
November, 2001 FDA 483 Response Mark P.Figgie, M.D. - Form 483R, 2002-01-04
February, 2004 EIR Sandra C. Belmont, M.D. - EIR, 2004-02-10
February, 2002 FDA 483 AMA Laboratories, Inc. - Form 483, 2002-02-26
March, 2001 EIR Dr. Jeffrey W. Moses - EIR, 2001-03-09
February, 2004 FDA 483 Sandra C. Belmont, M.D. - Form 483, 2004-02-10
July, 2001 EIR American Health Foundation - EIR, 2001-07-20
May, 2003 FDA 483 Response Blair Ford, MD - Form 483R, 2003-06-01
November, 2002 FDA 483 Barr Laboratories Inc. - Form 483, 2002-11-12
May, 2001 FDA 483 Samin K. Sharma - Form 483, 2001-05-18
March, 2001 FDA 483 Scioptic International - Form 483, 2001-03-27
March, 2005 EIR Orthometrix, Inc. - EIR, 2005-03-04
May, 2001 EIR James C.-Y Chou, M.D. - EIR, 2001-05-02
March, 2005 FDA 483 Response Orthometrix, Inc. - Form 483R, 2005-03-08
April, 2004 FDA 483 Continuum Medical Group at DOCS - Form 483, 2004-04-15
November, 2001 FDA 483 Hospital For Special Surgery IRB - Form 483, 2001-11-20
July, 2001 FDA 483 American Health Foundation - Form 483, 2001-07-20
March, 2001 EIR Scioptic International - EIR, 2001-03-27

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more